A long-standing controversy with oral hypoglycemic drugs is that, while they lower blood glucose levels, there is little or no evidence that they add years to a patient's life. So, lower glucose levels in type 2 patients have, in effect, been little more than a controversial marker of disease. Until now.
According to a recent article in the New England Journal of Medicine, there is both good and bad news about diabetes. The bad news is that the occurrence of diabetes tripled between1990 and 2010 in the United States. We shouldn t be surprised at this, since obesity prevalence a major risk factor for diabetes has also increased. The good news, however, is that the rate of the major complications of diabetes has dropped significantly over that same period of time.